TPG Capital led a $160m Series B funding round in Monogram Health.

TPG Capital led a $160m Series B funding round in Monogram Health, a kidney disease benefit management and care delivery company, with participation from Frist Cressey Ventures, Norwest Venture and Humana. “Welcoming TPG Capital alongside noted national and regional strategic investors further validates our industry leading kidney model of care. We look forward to working with the TPG team as Monogram further solidifies its role as the preeminent leader in personalized, compassionate, and evidence-based kidney care for patients,” Bill Frist, Monogram Health Chairman.